CD4 and coinfection: Overall, studies evaluating the influence of HBV/HIV coinfection on HIV RNA suppression, immunologic CD4 cell count recovery, and clinical outcomes in individuals on HAART have been limited and conflicting, with several studies finding no substantial impact of HBV coinfection on immunologic or HIV virologic responses to ART [46–53].